News & Events
ECR 2023
Attending ECR 2023? Stop by our booth to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.
Combinostics to Showcase Comprehensive Solutions for the Entire Patient Care Pathway of Neurological Disorders at RSNA
New and existing tools, including cPET, cARIA, and the Dementia Differential Analysis report, extend Combinostics’ solution beyond neurological image quantification and support end-to-end workflows.
Fountain Health Announces Full Coverage On Neurological Imaging
Fountain Health announces 100 percent coverage of Combinostics cMRI and cDSI. The company is now the first and only health insurance platform to provide complete coverage for the AI-enabled neurological imaging and decision support solutions.
Combinostics Adds Industry Experts to Leadership Team
Dr. Erik Post and Dr. Hans-Peter Huber have joined Combinostics as Group Chief Financial Officer (CFO) and Vice President of European Sales, respectively. Their contributions include considerable experience scaling software solutions.
RSNA 2022
Attending RSNA 2022? Stop by booth 3938 in the AI Showcase to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.
14th Radiologie Kongress Ruhr (RKR)
Attending the 14th Radiologie Kongress Ruhr (RKR)? Stop by booth 4.09 in Hall 1 to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.
ECTRIMS 2022
Attending ECTRIMS 2022? Stop by booth C28 to learn about our complete solution for the early detection, diagnosis, and management of multiple sclerosis and other major neurological disorders, including our clinically focused multiple sclerosis report.
Röntgenveckan 2022
Attending Röntgenveckan 2022? Stop by booth H01:05 to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.
Combinostics’ cDSI and cMRI Applications, Part of the cNeuro Platform, Receive EC-certification Under the EU’s Medical Device Regulation (MDR)
cNeuro® cDSI™ and cNeuro cMRI™ achieve EC-certification under MDR, ensuring continued delivery of services to European customers.
